Bipolar disorder comorbid with alcoholism: A 1H magnetic resonance spectroscopy study

Journal of Psychiatric Research

Volumn 44, Issue 5, 2010, Pages 278-285

  Nery, Fabiano G ^a,b,c   Stanley, Jeffrey A ^d   Chen, Hua Hsuan ^a   Hatch, John P ^a   Nicoletti, Mark A ^e   Serap Monkul, E ^a,c   Lafer, Beny ^c   Soares, Jair C ^e  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Alcoholism; Bipolar disorder; Glutamate; Magnetic resonance spectroscopy; Prefrontal cortex

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CENTRAL STIMULANT AGENT; CHOLINE DERIVATIVE; CREATINE; CREATINE PHOSPHATE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; LITHIUM CARBONATE; N ACETYLASPARTIC ACID; SEROTONIN UPTAKE INHIBITOR;

ADULT; ALCOHOLISM; AMINO ACID BRAIN LEVEL; ARTICLE; BIPOLAR DISORDER; CANNABIS ADDICTION; CLINICAL ARTICLE; COCAINE DEPENDENCE; COMORBIDITY; CONTROLLED STUDY; FEMALE; FUNCTIONAL STATUS; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MALE; MANIA; NEUROBIOLOGY; NEUROPATHOLOGY; OPIATE ADDICTION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REMISSION; SECOND MESSENGER; SEX DIFFERENCE; YOUNG MANIA RATING SCALE;

ADULT; AGE FACTORS; ALCOHOLISM; ANALYSIS OF VARIANCE; ASPARTIC ACID; BIPOLAR DISORDER; BRAIN; COMORBIDITY; CREATINE; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PHOSPHOCREATINE; SEX FACTORS;

EID: 77649338099     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2009.09.006     Document Type: Article

References (53)

1. Adinoff B. Neurobiologic processes in drug reward and addiction. Harvard Review of Psychiatry 12 (2004) 305-320
2. Adinoff B., Devous Sr. M.D., Cooper D.B., Best S.E., Chandler P., Harris T., et al. Resting regional cerebral blood flow and gambling task performance in cocaine-dependent subjects and healthy comparison subjects. American Journal of Psychiatry 160 (2003) 1892-1894
3. Bartha R., Drost D.J., Menon R.S., and Williamson P.C. Comparison of the quantification of human short echo time (1)H spectroscopy at 1.5 and 4.0 T. Magnetic Resonance in Medicine 44 (2000) 185-192
4. Bartsch A.J., Homola G., Biller A., Smith S.M., Weijers H.G., Wiesbeck G.A., et al. Manifestations of early brain recovery associated with abstinence from alcoholism. Brain 130 (2007) 36-47
5. Bendszus M., Weijers H.G., Wiesbeck G., Warmuth-Metz M., Bartsch A.J., Engels S., et al. Sequential MR imaging and proton MR spectroscopy in patients who underwent recent detoxification for chronic alcoholism:correlation with clinical and neuropsychological data. AJNR American Journal of Neuroradiology 22 (2001) 1926-1932
6. Bhagwagar Z., Wylezinska M., Jezzard P., Evans J., Ashworth F., Sule A., et al. Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects. Biological Psychiatry 15 61 (2007) 806-812
7. Bolla K.I., Eldreth D.A., Matochik J.A., and Cadet J.L. Neural substrates of faulty decision-making in abstinent marijuana users. Neuroimage 26 (2005) 480-492
8. Chang K., Adleman N., Dienes K., Barnea-Goraly N., Reiss A., and Ketter T. Decreased N-acetylaspartate in children with familial bipolar disorder. Biological Psychiatry 53 (2003) 1059-1065
9. Dager S.R., Friedman S.D., Parow A., Demopulos C., Stoll A.L., Lyoo I.K., et al. Brain metabolic alterations in medication-free patients with bipolar disorder. Archives of General Psychiatry 61 (2004) 450-458
10. de Graaf A.A., and Bovee W.M. Improved quantification of in vivo 1H NMR spectra by optimization of signal acquisition and processing and by incorporation of prior knowledge into the spectral fitting. Magnetic Resonance in Medicine 15 (1990) 305-319
11. D'Esposito M. Executive functions and frontal systems. In: Schiffer R.B., Rao S.M., and Fogel B.S. (Eds). Neuropsychiatry. 2nd ed. (2003), Lippincott Williams & Wilkins, Philadelphia, USA 328-337
12. Durazzo T.C., Gazdzinski S., Banys P., and Meyerhoff D.J. Cigarette smoking exacerbates chronic alcohol-induced brain damage: a preliminary metabolite imaging study. Alcoholism Clinical and Experimental Research 28 (2004) 1849-1860
13. Ende G., Welzel H., Walter S., Weber-Fahr W., Diehl A., Hermann D., et al. Monitoring the effects of chronic alcohol consumption and abstinence on brain metabolism: a longitudinal proton magnetic resonance spectroscopy study. Biological Psychiatry 58 (2005) 974-980
14. Erecinska M., and Silver I.A. Metabolism and role of glutamate in mammalian brain. Progress in Neurobiology 35 (1990) 245-296
15. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured clinical interview for DSM-IV axis disorders (1995), State Psychiatric Institute, Biometrics Research, New York, NY
16. Frey B.N., Stanley J.A., Nery F.G., Monkul E.S., Nicoletti M.A., Chen H.H., et al. Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: an in vivo 1H MRS study. Bipolar Disorders 9 Suppl. 1 (2007) 119-127
17. Frye M.A., and Salloum I.M. Bipolar disorder and comorbid alcoholism: prevalence rate and treatment considerations. Bipolar Disorders 8 (2006) 677-685
18. Frye M.A., Altshuler L.L., McElroy S.L., Suppes T., Keck P.E., Denicoff K., et al. Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder. American Journal of Psychiatry 160 (2003) 883-889
19. Frye M.A., Watzl J., Banakar S., O'Neill J., Mintz J., Davanzo P., et al. Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression. Neuropsychopharmacology 32 (2007) 2490-2499
20. Goff D.C., Hennen J., Lyoo K., Tsai G., Wald L.L., Evins A.E., et al. Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine. Biological Psychiatry 15 (2002) 493-497
21. Hamilton M. Hamilton psychiatric rating scale for depression. In: Guy W. (Ed). ECDEU assessment manual for psychopharmacology (1976), Department of Health, Washington, DCL, US 179-192
22. Hasin D. Classification of alcohol use disorders. Alcohol Research and Health 27 (2003) 5-17
23. Jackson G.D., and Duncan J.S. MRI anatomy: a new angle on the brain (1996), Churchill Livingstone, New York
24. Kalivas P.W., and Volkow N.D. The neural basis of addiction: a pathology of motivation and choice. American Journal of Psychiatry 162 (2004) 1403-1413
25. Kam K., and Nicoll R. Excitatory synaptic transmission persists independently of the glutamate-glutamine cycle. Journal of Neurosciences 27 (2007) 9192-9200
26. Krystal J.H., Sanacora G., Blumberg H., Anand A., Charney D.S., Marek G., et al. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Molecular Psychiatry 7 (2002) S71-S80
27. Lee E., Jang D.P., Kim J.J., An S.K., Park S., Kim I.Y., et al. Alteration of brain metabolites in young alcoholics without structural changes. Neuroreport 18 (2007) 1511-1514
28. Magistretti P.J., and Pellerin L. Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 354 (1999) 1155-1163
29. Michael N., Erfurth A., Orhmann P., Gössling M., Arolt V., Heindel W., et al. Acute mania is accompanied by elevated glutamate/glutamine levels within the left dorsolateral prefrontal cortex. Psychopharmacology 168 (2003) 344-346
30. Molina V., Sánchez J., Sanz J., Reig S., Benito C., Leal I., et al. Dorsolateral prefrontal N-acetyl-aspartate concentration in male patients with chronic schizophrenia and with chronic bipolar disorder. European Psychiatry 22 (2007) 505-512
31. Parks M.H., Dawant B.M., Riddle W.R., Hartmann S.L., Dietrich M.S., Nickel M.K., et al. Longitudinal brain metabolic characterization of chronic alcoholics with proton magnetic resonance spectroscopy. Alcoholism Clinical and Experimental Research 26 (2002) 1368-1380
32. Petrakis I.L., Limoncelli D., Gueorguieva R., Jatlow P., Boutros N.N., Trevisan L., et al. Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism. American Journal of Psychiatry 161 (2004) 1776-1782
33. Pfefferbaum A., Lim K.O., Zipursky R.B., Mathalon D.H., Rosenbloom M.J., Lane B., et al. Brain gray and white matter volume loss accelerates with aging in chronic alcoholics: a quantitative MRI study. Alcoholism Clinical and Experimental Research 16 (1992) 1078-1089
34. Provencher S.W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance in Medicine 30 (1993) 672-679
35. Rothman D.L., Hanstock C.C., Petroff O.A., Novotny E.J., Prochard J.W., and Shulman R.G. Localized 1H NMR spectra of glutamate in the human brain. Magnetic Resonance in Medicine 25 (1992) 94-106
36. Sanacora G., Mason G.F., Rothman D.L., and Krystal J.H. Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. American Journal of Psychiatry 159 (2002) 663-665
37. Sassi R.B., Stanley J.A., Axelson D., Brambilla P., Nicoletti M.A., Keshavan M.S., et al. Reduced NAA levels in the dorsolateral prefrontal cortex of young bipolar patients. American Journal of Psychiatry 162 (2005) 2109-2115
38. Schirmer T., and Auer D.P. On the reliability of quantitative clinical magnetic resonance spectroscopy of the human brain. NMR in Biomedicine 13 (2000) 28-36
39. Schloesser R.J., Huang J., Klein P.S., and Manji H.K. Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 33 (2008) 110-133
40. Schubert F., Gallinat J., Seifert F., and Rinneberg H. Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 T. Neuroimage 21 (2004) 1762-1771
41. Schuckit M.A., and Smith T.L. An 8-year follow-up of 450 sons of alcoholic and control subjects. Archives of General Psychiatry 53 (1996) 202-210
42. Schumann G., Johann M., Frank J., Preuss U., Dahmen N., Laucht M., et al. Systematic analysis of glutamatergic neurotransmission genes in alcohol dependence and adolescent risky drinking behavior. Archives of General Psychiatry 65 (2008) 826-838
43. Seeger U., Klose U., Mader I., Grodd W., and Nagele T. Parameterized evaluation of macromolecules and lipids in proton MR spectroscopy of brain diseases. Magnetic Resonance in Medicine 49 (2003) 19-28
44. Silverstone P.H., Wu R.H., O'Donnell T., Ulrich M., Asghar S.J., and Hanstock C.C. Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients. International Clinical Psychopharmacology 18 (2003) 73-79
45. Smith S.M., Jenkinson M., Woolrich M., Beckmann C.F., Behrens T.E., Johansen-Berg H., et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23 Suppl. 1 (2004) S208-S219
46. Soares J.C. Contributions from brain imaging to the elucidation of pathophysiology of bipolar disorder. International Journal of Neuropsychopharmacology 6 (2003) 171-180
47. Stanley J.A. In vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders. Canadian Journal of Psychiatry 47 (2002) 315-326
48. Stanley J.A., Drost D.J., Williamson P.C., and Thompson R.T. The use of a priori knowledge to quantify short echo in vivo 1H MR spectra. Magnetic Resonance in Medicine 34 (1995) 17-24
49. Stanley J.A., Pettegrew J.W., and Keshavan M.S. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings - part I. Biological Psychiatry 48 (2000) 357-368
50. Sullivan E.V., and Pfefferbaum A. Neurocircuitry in alcoholism: a substrate of disruption and repair. Psychopharmacology 180 (2005) 583-594
51. Weiss R.D., Ostacher M.J., Otto M.W., Calabrese J.R., Fossey M., Wisniewski S.R., et al. Does recovery from substance use disorder matter in patients with bipolar disorder?. Journal of Clinical Psychiatry 66 (2005) 730-735
52. Winsberg M.E., Sachs N., Tate D.L., Adalteinsson E., Spielman D., and Ketter T.A. Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biological Psychiatry 47 (2000) 475-481
53. Young R.C., Biggs J.T., Ziegler V.E., and Meyer D.A. A rating scale for mania: reliability, validity and sensibility. British Journal of Psychiatry 133 (1978) 429-435